MOSCA, MARTA Statistiche

MOSCA, MARTA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 306 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 1-gen-2019 Aringer, M; Costenbader, K; Daikh, D; Brinks, R; Mosca, M; Ramsey-Goldman, R; Smolen, Js; Wofsy, D; Boumpas, Dt; Kamen, Dl; Jayne, D; Cervera, R; Costedoat-Chalumeau, N; Diamond, B; Gladman, Dd; Hahn, B; Hiepe, F; Jacobsen, S; Khanna, D; Lerstrøm, K; Massarotti, E; Mccune, J; Ruiz-Irastorza, G; Sanchez-Guerrero, J; Schneider, M; Urowitz, M; Bertsias, G; Hoyer, Bf; Leuchten, N; Tani, C; Tedeschi, Sk; Touma, Z; Schmajuk, G; Anic, B; Assan, F; Chan, Tm; Clarke, Ae; Crow, Mk; Czirják, L; Doria, A; Graninger, W; Halda-Kiss, B; Hasni, S; Izmirly, Pm; Jung, M; Kumánovics, G; Mariette, X; Padjen, I; Pego-Reigosa, Jm; Romero-Diaz, J; Rúa-Figueroa Fernández, Í; Seror, R; Stummvoll, Gh; Tanaka, Y; Tektonidou, Mg; Vasconcelos, C; Vital, Em; Wallace, Dj; Yavuz, S; Meroni, Pl; Fritzler, Mj; Naden, R; Dörner, T; Johnson, Sr
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 1-gen-2019 Fanouriakis, A; Kostopoulou, M; Alunno, A; Aringer, M; Bajema, I; Boletis, Jn; Cervera, R; Doria, A; Gordon, C; Govoni, M; Houssiau, F; Jayne, D; Kouloumas, M; Kuhn, A; Larsen, Jl; Lerstrøm, K; Moroni, G; Mosca, M; Schneider, M; Smolen, Js; Svenungsson, E; Tesar, V; Tincani, A; Troldborg, A; van Vollenhoven, R; Wenzel, J; Bertsias, G; Boumpas, Dt
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 1-gen-2020 Fanouriakis, A; Kostopoulou, M; Cheema, K; Anders, Hj; Aringer, M; Bajema, I; Boletis, J; Frangou, E; Houssiau, Fa; Hollis, J; Karras, A; Marchiori, F; Marks, Sd; Moroni, G; Mosca, M; Parodis, I; Praga, M; Schneider, M; Smolen, Js; Tesar, V; Trachana, M; van Vollenhoven, Rf; Voskuyl, Ae; Teng, Yko; van Leew, B; Bertsias, G; Jayne, D; Boumpas, Dt
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. 1-gen-1999 Neri, R; Mosca, Marta; Bernacchi, E; Bombardieri, Stefano
A case of undifferentiated connective tissue disease: is it a distinct clinical entity? 1-gen-2008 Mosca, Marta; Tani, C; Bombardieri, Stefano
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 1-gen-2006 Moroni, G; Doria, A; Mosca, Marta; Alberighi, Od; Ferraccioli, G; Todesco, S; Manno, C; Altieri, P; Ferrara, R; Greco, S; Ponticelli, C.
Aderenza allo screening per il cancro della cervice uterina in una coorte italiana di donne affette da LES [Adherence to cervical cancer screening in an Italian SLE cohort] 1-gen-2011 Tani, C; Carli, L; Mosca, Marta; Baldini, Chiara; Consensi, A; Doveri, M; Talarico, R; Bombardieri, Stefano
Adherence to treatment in Behçet's syndrome: a multi-faceted issue 1-gen-2021 Pirri, S; Marinello, D; Lorenzoni, V; Andreozzi, G; Bazzani, A; Del Bianco, A; Turchetti, G; Mosca, M; Talarico, R
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis 1-gen-2013 Della Rossa, A; Cazzato, M; D'Ascanio, A; Tavoni, A; Bencivelli, W; Pepe, P; Mosca, Marta; Baldini, Chiara; Rossi, Marco; Bombardieri, Stefano
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 1-gen-2012 Della Rossa, A; Cazzato, M; D'Ascanio, A; Tavoni, A; Bencivelli, Valter; Pepe, P; Mosca, Marta; Baldini, Chiara; Rossi, M; Bombardieri, Stefano
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity 1-gen-2004 Liang, M. H.; Fortin, P.; Schneider, M.; Abrahamowicz, M.; Alarcón, G. S.; Bombardieri, S.; Balow, J.; Benito Garcia, E.; Bischoff Ferrari, H.; Buyon, J.; Chehab, G.; Costenbader, K.; Crofford, L.; De Pablo, P.; Esdaile, J. M.; Finckh, A.; Fischer Betz, R.; Gladman, D.; Gordon, C.; Illei, G.; Isenberg, D.; Iking Konert, C.; Johnson, K.; Kalden, J.; Khamashta, M.; Koike, T.; Lockshin, M.; Manzi, S.; Mccune, J.; Meyrier, A.; Mikdashi, J.; Moore, A.; Mosca, Marta; Petri, M.; Phillips, C.; Roberts Jr, . N.; Schur, P.; Smolen, J.; Stclair, S. t. Clair E. W.; Strand, V.
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 1-gen-2019 Sota, J; Rigante, D; Ruscitti, P; Insalaco, A; Sfriso, P; de Vita, S; Cimaz, R; Lopalco, G; Emmi, G; La Torre, F; Fabiani, C; Olivieri, An; Cattalini, M; Cammelli, D; Gallizzi, R; Alessio, M; Manna, R; Viapiana, O; Frassi, M; Pardeo, M; Maier, A; Salvarani, C; Talarico, R; Mosca, M; Colafrancesco, S; Priori, R; Maggio, Mc; Gaggiano, C; Grosso, S; De Benedetti, F; Vitale, A; Giacomelli, R; Cantarini, L.
Analysis of the evolution of UCTD to defined CTD after a long term follow-up 1-gen-2013 Mosca, M; Tani, C; Carli, L; Della Rossa, A; Talarico, R; Baldini, C; Bombardieri, S.
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity 1-gen-2013 Carli, L; Tani, Chiara; Querci, F; Della Rossa, A; Vagnani, S; Baldini, Chiara; Talarico, R; D'Ascanio, A; Neri, R; Tavoni, Ag; Bombardieri, Stefano; Mosca, Marta
Anti-C1q antibodies in pregnant patients with systemic lupus eruthematosus 1-gen-2007 Mosca, Marta; Strigini, FRANCESCA ANNA LETIZIA; Doria, A; Pratesi, Federico; Tani, C; Iaccarino, L; Chimenti, D; Carmignani, A; Cecchi, M; Zampieri, S; Ghirardello, A; Migliorini, Paola; Bombardieri, Stefano
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group 1-gen-2014 Scarsi, M1; Radice, A; Pregnolato, F; Ramoni, V; Grava, C; Bianchi, L; Gerosa, M; Mosca, M; Ghirardello, A; Tani, C; Motta, Maurizio; Quinzanini, M; Tincani, A; Ruffatti, A; Migliorini, P; Doria, A; Meroni, Pl; Brucato, A.
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the “Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group” 1-gen-2014 Scarsi, M; Radice, A; Pregnolato, F; Ramoni, V; Grava, C; Bianchi, L; Gerosa, M; Mosca, Marta; Ghirardello, A; Tani, C; Motta, M; Quinzanini, M; Tincani, A; Ruffatti, A; Migliorini, Paola; Doria, A; Meroni, Pl; Brucato, A.
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy 1-gen-2006 Hengstman, Gj; TER LAAK, Hj; VREE EGBERTS, Wt; Lundberg, Ie; Moutsopoulos, Hm; Vencovsky, J; Doria, A; Mosca, Marta; VAN VENROOIJ, Wj; VAN ENGELEN, Bg
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients 1-gen-2002 Cervera, R; Piette, Jc; Font, J; Khamashta, Ma; Shoenfeld, Y; Camps, Mt; Jacobsen, S; Lakos, G; Tincani, A; KONTOPOULOU GRIVA, I; Galeazzi, M; Meroni, Pl; Derksen, Rh; De, ; Groot, Pg; GROMNICA IHLE, E; Baleva, M; Mosca, Marta; Bombardieri, Stefano; Houssiau, F; Gris, Jc; Quéré, I; Hachulla, E; Vasconcelos, C; Roch, B; FERNÁNDEZ NEBRO, A; Boffa, Mc; Hughes, Gr; Ingelmo, M; EURO PHOSPHOLIPID PROJECT, Group
Antiphospholipid syndrome: state of the art on clinical practice guidelines 1-gen-2018 : Limper, M; Scirè, Ca; Talarico, R; Amoura, Z; Avcin, T; Basile, M; Burmester, G; Carli, L; Cervera, R; Costedoat-Chalumeau, N; Doria, A; Dörner, T; Fonseca, Je; Galetti, I; Hachulla, E; Launay, D; Lourenco, F; Macieira, C; Meroni, P; Montecucco, Cm; Moraes-Fontes, Mf; Mouthon, L; Nalli, C; Ramoni, V; Tektonidou, M; van Laar, Jm; Bombardieri, S; Schneider, M; Smith, V; Vieira, A; Cutolo, M; Mosca, M; Tincani, A.